PA LEE: Open Payments
NPI 1528425105 · CLAREMONT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 82 payments from 20 companies in 2025. Trend: 2023 $954 · 2024 $1,079 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $260 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| PFIZER INC. | 8 | $137 |
| Lilly USA, LLC | 7 | $129 |
| Novo Nordisk Inc | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Corcept Therapeutics | 5 | $70 |
| Phathom Pharmaceuticals, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
Products named: UBRELVY, MOUNJARO, REXULTI, FARXIGA, VRAYLAR, Korlym, VOQUEZNA, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
